HS-20004

DRUG4 trials

Sponsors

Jiangsu Hansoh Pharmaceutical Co., Ltd., Jiangsu HengRui Medicine Co., Ltd.

Conditions

Diabetes Mellitus, Type 2Healthy

Phase 1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple s.c Doses HS-20004 in Healthy Chinese Volunteers

CompletedNCT02746315

Jiangsu Hansoh Pharmaceutical Co., Ltd.Healthy

Start: 2014-10-31Updated: 2016-04-21

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Volunteers

CompletedNCT02746302

Jiangsu Hansoh Pharmaceutical Co., Ltd.Healthy

Start: 2012-12-31End: 2014-05-31Updated: 2016-04-21

Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients

Jiangsu Hansoh Pharmaceutical Co., Ltd.Diabetes Mellitus, Type 2

Start: 2015-12-31Target: 12Updated: 2016-04-25

Phase 2

A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.

CompletedNCT03848793

Jiangsu HengRui Medicine Co., Ltd.Diabetes Mellitus, Type 2

Start: 2019-03-06End: 2020-12-14Updated: 2022-11-07